Navigation Links
Oil palm plantations are no substitute for tropical rainforests, a new study shows
Date:9/15/2008

ical rainforest in Central Africa, Latin America and Southeast Asia. Where oil palm has replaced tropical forest the impact on wildlife depends on what species survive in the new oil palm habitat.

The study confirmed that oil palm is a poor substitute habitat for the majority of tropical forest species, particularly forest specialists and those of conservation concern.

Emily Fitzherbert continues: "By compiling scientific studies of birds, bats, ants and other species, we were able to show that on average, fewer than one-sixth of the species recorded in primary forest were found in oil palm. Degraded forest, and even alternative crops such as rubber and cocoa, supported higher numbers of species than oil palm plantations."

Even this estimate is likely to be optimistic, because forest habitats are more difficult to survey and some species inhabit plantations briefly before going extinct.

There is little potential to help wildlife within plantations, so ensuring that new plantations do not replace forest and protecting what is left of native forest in and around plantations are the only real options for protecting the majority of species, the researchers say.

International policies demanding evidence of environmental responsibility, in particular that land of high conservation value is not converted to oil palm, can help.

"There is enough non-forested land suitable for plantation development to allow large increases in production without further deforestation," said co-author Ben Phalan, from the University of Cambridge.

However, in identifying these areas, there needs to be a careful distinction between degraded land that is of low conservation value, such as imperata grasslands, and partially logged or degraded forest areas which can still harbour relatively high levels of biodiversity and bring greater wildlife and carbon storage benefits if restored.

"Unless governments in producer countri
'/>"/>

Contact: Sian Halkyard
s.halkyard@qmul.ac.uk
07-970-096-175
Queen Mary, University of London
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures
2. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
3. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
4. Germicidal UVC Lights Improve Clinical Pregnancy Rates for IVF Lab, New Study Finds
5. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
6. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
7. Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes
8. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
9. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
10. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
11. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...would like to be able to charge their cell phones ... often. A recent discovery made by UC San Diego en...apacitors that could do just this. , In recent ...Prabhakar Bandaru, a professor in the UCSD Departm... with graduate student Mark Hoefer, have found tha...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-FirstCal...novator in biotechnology for diabetes therapy, and... services to food, supplement, biotechnology and p... the previously reported $6.3 million registered d...0,870 shares of its common stock and warrants to p...
(Date:11/19/2009)... MUNSTER, Germany, November 19 MO... on November 16th, 2009 Flibanserin in the,indicat... in Parkinson,s,disease for orphan drug status des.... Levodopa-induced dyskinesia is a complication of...d a serious burden to some of those,affected, sinc...
(Date:11/19/2009)... InSound is honored by latest award for r... Newark, CA (PRWEB) November 16, 2009 -- Popular...ible” hearing aid from InSound Medical a win...in the Health category.    Cho...to reside deep in the hearing canal for up to four...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...vests to advance expanding pipeline of products to... PARIS, Dec. 12 Fovea Pharmaceuticals SA, a,bioph... for the treatment,of ophthalmic diseases announce... financing from a strong, international syndicate ...al Partners (Naarden, The,Netherlands). All existi...
... cars are reaching commercial viability in todays ...eir promise, even scientists have struggled to exp...e proton exchange membrane really works. , How... of Energys Ames Laboratory has offered a new mode...he membranes structure and how it functions. And a...
...ymbol: MS, EDMONTON, Dec. 11 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...Monitoring Board (DSMB) has,reviewed data from the...III,clinical trial of MBP8298 for the treatment of... trial continue., This was the first of several r...
Other Biology Technology:Fovea Pharmaceuticals Completes EUR30M Series B Financing 2Fovea Pharmaceuticals Completes EUR30M Series B Financing 3Fovea Pharmaceuticals Completes EUR30M Series B Financing 4Ames Laboratory researchers solve fuel-cell membrane structure conundrum 2BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2
(Date:11/20/2009)...duction of a single bacterial gene into yeast, res...e Netherlands achieved three improvements in bioet... ,More ethanol, less acetate and elimination of th...on was published in the scientific journal Applie... , Bioethanol is made by the yeast Saccharomyces ...
(Date:11/20/2009)...ctive pulmonary disease (COPD), a respiratory dise...ema, is the fourth leading cause of death worldwid...searchers have yet to find any real treatment or c...t The University of Western Ontario in London, Can...ew insight into the disease. , Parraga is a ...
(Date:11/19/2009)...ly 15,000 years ago, at the end of the last ice ag...s including such iconic creatures as mammoths, ma...eavers began their precipitous slide to extinctio...g a land whose diversity of large animals equaled ...ns then or now, an entirely novel ecosystem emerge...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Gaining a better picture of lung disease 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Medical Safety Net in Florida to Strengthen with Recent Grants 49925 1Medical Safety Net in Florida to Strengthen with Recent Grants 49925 2First Day of Summer Has Come 3A Enjoy the Summer Sunshine Without Putting Yourself at Risk 49922 1First Day of Summer Has Come 3A Enjoy the Summer Sunshine Without Putting Yourself at Risk 49922 2First Day of Summer Has Come 3A Enjoy the Summer Sunshine Without Putting Yourself at Risk 49922 3Heritage Summit HealthCare Inc Contracts with Mayo Clinic for Workers Compensation Care 49919 1Heritage Summit HealthCare Inc Contracts with Mayo Clinic for Workers Compensation Care 49919 2Heritage Summit HealthCare Inc Contracts with Mayo Clinic for Workers Compensation Care 49919 3
...eveloped a novel method for attaching small molecu... then are used to capture large biomolecules. By ...olecules, researchers can make the technique appli...drugs, chemical warfare agents, and environmental ... to identify synthetic biomolecules that recognize...
...blisher for Physics, Mathematics and Computer Scie...e CERN and DESY high-energy physics laboratories. ...trally cover article-processing charges for all re...r-reviewed open access journal, PMC Physics A. , ...University of Oxford and Royal Holloway and was la...
...staple for people planning their day. Now with the...to broaden daily forecasts to include predictions ... some parts of the world. , Some scientists predi...orecasts of air pollution near the ground, where i...Such a system could prove useful in efforts to imp...
Other Biology News:Biocapture surfaces produced for study of brain chemistry 2Top physics laboratories sign up to open access with PhysMath Central 2Air quality forecasts see future in space 2Air quality forecasts see future in space 3
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Mouse Anti-Human STAU2 Monoclonal Antibody, Unconjugated, Clone 6F9 from Abnova Corporation
Mouse Anti-Human NR2F2 Polyclonal Antibody, Unconjugated from Novus Biologicals
Mouse Anti-Human YARS Monoclonal Antibody, Unconjugated, Clone 2F3 from Abnova Corporation
Biology Products: